1887

Abstract

Nef is a multifunctional protein of the human immunodeficiency virus type 1 (HIV-1) required for high viral replication and disease progression. Several findings indicate that the capacity of Nef to downregulate surface CD4 is essential for the protein's pathogenic activity, although the mechanisms that link the two functions are yet unclear. It is believed that, by reducing surface CD4 levels, Nef counteracts the receptor's negative effects on virion infectivity and release. Here, we show that, in 293T cells co-expressing CD4 and HIV-1, the capacity of Nef to enhance the virion incorporation of Env products and release of viral particles was mediated by retention-degradation of neo-synthesized CD4 rather than by accelerated receptor endocytosis. Different results were observed in primary CD4 T lymphocytes in which Nef-mediated CD4 downregulation occurs primarily by accelerated internalization. In HIV-infected T cell cultures, Nef was crucial for the removal of surface CD4 at the beginning of the infection, while later on maximal CD4 downregulation was achieved in a Nef-independent manner. Moreover, by means of selected Nef mutants, we observed that CD4 downregulation is not essential for Nef ability to enhance Env incorporation into virions and increase viral infectivity or replication in CD4 T lymphocytes. Notably, Nef expression itself was dispensable for efficient release of HIV-1 particles by T cells. In conclusion, we propose that the CD4 downregulation activity of Nef plays a role before the late productive phases of HIV-1 replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.026005-0
2011-01-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/1/141.html?itemId=/content/journal/jgv/10.1099/vir.0.026005-0&mimeType=html&fmt=ahah

References

  1. Ahr, B., Robert-Hebmann, V., Devaux, C. & Biard-Piechaczyk, M. ( 2004; ). Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology 1, 12 [CrossRef]
    [Google Scholar]
  2. Aiken, C. & Trono, D. ( 1995; ). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 69, 5048–5056.
    [Google Scholar]
  3. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. & Trono, D. ( 1994; ). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853–864.[CrossRef]
    [Google Scholar]
  4. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C. & Cullen, B. R. ( 1993; ). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral super infection. J Exp Med 177, 1561–1566.[CrossRef]
    [Google Scholar]
  5. Carl, S., Greenough, T. C., Krumbiegel, M., Greenberg, M., Skowronski, J., Sullivan, J. L. & Kirchhoff, F. ( 2001; ). Modulation of different human immunodeficiency virus type 1 nef functions during progression to AIDS. J Virol 75, 3657–3665.[CrossRef]
    [Google Scholar]
  6. Casartelli, N., Di Matteo, G., Potestà, M., Rossi, P. & Doria, M. ( 2003; ). CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol 77, 11536–11545.[CrossRef]
    [Google Scholar]
  7. Casartelli, N., Giolo, G., Neri, F., Haller, C., Potestà, M., Rossi, P., Fackler, O. T. & Doria, M. ( 2006; ). The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner. J Gen Virol 87, 2291–2296.[CrossRef]
    [Google Scholar]
  8. Cerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., Santoni, A. & Doria, M. ( 2007; ). Human immunodeficiency virus 1 nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88, 242–250.[CrossRef]
    [Google Scholar]
  9. Chazal, N., Singer, G., Aiken, C., Hammarskjold, M. L. & Rekosh, D. ( 2001; ). Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require nef for optimal infectivity. J Virol 75, 4014–4018.[CrossRef]
    [Google Scholar]
  10. Chen, B. K., Gandhi, R. T. & Baltimore, D. ( 1996; ). CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 70, 6044–6053.
    [Google Scholar]
  11. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D. & Guatelli, J. C. ( 1994; ). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 68, 2906–2914.
    [Google Scholar]
  12. Chowers, M. Y., Pandori, M. W., Spina, C. A., Richman, D. D. & Guatelli, J. C. ( 1995; ). The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451–457.[CrossRef]
    [Google Scholar]
  13. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A. & other authors ( 1995; ). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988–991.[CrossRef]
    [Google Scholar]
  14. Doria, M., Neri, F., Gallo, A., Farace, M. G. & Michienzi, A. ( 2009; ). Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 37, 5848–5858.[CrossRef]
    [Google Scholar]
  15. Fackler, O. T., Moris, A., Tibroni, N., Giese, S. I., Glass, B., Schwartz, O. & Krausslich, H. G. ( 2006; ). Functional characterization of HIV-1 nef mutants in the context of viral infection. Virology 351, 322–339.[CrossRef]
    [Google Scholar]
  16. Geleziunas, R., Bour, S. & Wainberg, M. A. ( 1994; ). Cell surface down-modulation of CD4 after infection by HIV-1. FASEB J 8, 593–600.
    [Google Scholar]
  17. Gervaix, A., West, D., Leoni, L. M., Richman, D. D., Wong-Staal, F. & Corbeil, J. ( 1997; ). A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc Natl Acad Sci U S A 94, 4653–4658.[CrossRef]
    [Google Scholar]
  18. Geyer, M., Fackler, O. T. & Peterlin, B. M. ( 2001; ). Structure-function relationships in HIV-1 nef. EMBO Rep 2, 580–585.[CrossRef]
    [Google Scholar]
  19. Giolo, G., Neri, F., Casartelli, N., Potestà, M., Belleudi, F., Torrisi, M. R. & Doria, M. ( 2007; ). Internalization and intracellular retention of CD4 are two separate functions of the human immunodeficiency virus type 1 nef protein. J Gen Virol 88, 3133–3138.[CrossRef]
    [Google Scholar]
  20. Glushakova, S., Munch, J., Carl, S., Greenough, T. C., Sullivan, J. L., Margolis, L. & Kirchhoff, F. ( 2001; ). CD4 down-modulation by human immunodeficiency virus type 1 nef correlates with the efficiency of viral replication and with CD4+ T-cell depletion in human lymphoid tissue ex vivo. J Virol 75, 10113–10117.[CrossRef]
    [Google Scholar]
  21. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D. & Greene, W. C. ( 1995; ). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 nef. J Virol 69, 4112–4121.
    [Google Scholar]
  22. Gratton, S., Yao, X. J., Venkatesan, S., Cohen, E. A. & Sékaly, R. P. ( 1996; ). Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef. J Immunol 157, 3305–3311.
    [Google Scholar]
  23. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S. & Jolicoeur, P. ( 1998; ). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163–175.[CrossRef]
    [Google Scholar]
  24. Hanna, Z., Priceputu, E., Hu, C., Vincent, P. & Jolicoeur, P. ( 2006; ). HIV-1 nef mutations abrogating downregulation of CD4 affect other nef functions and show reduced pathogenicity in transgenic mice. Virology 346, 40–52.[CrossRef]
    [Google Scholar]
  25. Iafrate, A. J., Carl, S., Bronson, S., Stahl-Hennig, C., Swigut, T., Skowronski, J. & Kirchhoff, F. ( 2000; ). Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J Virol 74, 9836–9844.[CrossRef]
    [Google Scholar]
  26. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. ( 1991; ). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651–662.[CrossRef]
    [Google Scholar]
  27. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. ( 1995; ). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228–232.[CrossRef]
    [Google Scholar]
  28. Lama, J., Mangasarian, A. & Trono, D. ( 1999; ). Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking env incorporation in a nef- and vpu-inhibitable manner. Curr Biol 9, 622–631.[CrossRef]
    [Google Scholar]
  29. Lu, X., Yu, H., Liu, S. H., Brodsky, F. M. & Peterlin, B. M. ( 1998; ). Interactions between HIV1 nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8, 647–656.[CrossRef]
    [Google Scholar]
  30. Lundquist, C. A., Tobiume, M., Zhou, J., Unutmaz, D. & Aiken, C. ( 2002; ). Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol 76, 4625–4633.[CrossRef]
    [Google Scholar]
  31. Lundquist, C. A., Zhou, J. & Aiken, C. ( 2004; ). Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for nef in viral replication. J Virol 78, 6287–6296.[CrossRef]
    [Google Scholar]
  32. Malim, M. H. & Emerman, M. ( 2008; ). HIV-1 accessory proteins: ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388–398.[CrossRef]
    [Google Scholar]
  33. Mangasarian, A., Piguet, V., Wang, J. K., Chen, Y. L. & Trono, D. ( 1999; ). Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of nef selectively regulate MHC-I trafficking. J Virol 73, 1964–1973.
    [Google Scholar]
  34. Mariani, R., Kirchhoff, F., Greenough, T. C., Sullivan, J. L., Desrosiers, R. C. & Skowronski, J. ( 1996; ). High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 70, 7752–7764.
    [Google Scholar]
  35. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B. & Greene, W. C. ( 1995; ). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J Virol 69, 579–584.
    [Google Scholar]
  36. Neil, S. J., Zang, T. & Bieniasz, P. D. ( 2008; ). Tetherin inhibits retrovirus release and is antagonized by HIV-1 vpu. Nature 451, 425–430.[CrossRef]
    [Google Scholar]
  37. Oldridge, J. & Marsh, M. ( 1998; ). Nef: an adaptor adaptor? Trends Cell Biol 8, 302–305.[CrossRef]
    [Google Scholar]
  38. Patel, P. G., Yu Kimata, M. T., Biggins, J. E., Wilson, J. M. & Kimata, J. T. ( 2002; ). Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J Virol 76, 6425–6434.[CrossRef]
    [Google Scholar]
  39. Rose, J. J., Janvier, K., Chandrasekhar, S., Sekaly, R. P., Bonifacino, J. S. & Venkatesan, S. ( 2005; ). CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) nef proteins involves both internalization and intracellular retention mechanisms. J Biol Chem 280, 7413–7426.[CrossRef]
    [Google Scholar]
  40. Ross, T. M., Oran, A. E. & Cullen, B. R. ( 1999; ). Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral nef protein. Curr Biol 9, 613–621.[CrossRef]
    [Google Scholar]
  41. Schiavoni, I., Trapp, S., Santarcangelo, A. C., Piacentini, V., Pugliese, K., Baur, A. & Federico, M. ( 2004; ). HIV-1 nef enhances both membrane expression and virion incorporation of env products. A model for the nef-dependent increase of HIV-1 infectivity. J Biol Chem 279, 22996–23006.[CrossRef]
    [Google Scholar]
  42. Schindler, M., Munch, J., Kutsch, O., Li, H., Santiago, M. L., Bibollet-Ruche, F., Muller-Trutwin, M. C., Novembre, F. J., Peeters, M. & other authors ( 2006; ). Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055–1067.[CrossRef]
    [Google Scholar]
  43. Schwartz, O., Marechal, V., Danos, O. & Heard, J. M. ( 1995; ). Human immunodeficiency virus type 1 nef increases the efficiency of reverse transcription in the infected cell. J Virol 69, 4053–4059.
    [Google Scholar]
  44. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C. & Richman, D. D. ( 1994; ). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 179, 115–123.[CrossRef]
    [Google Scholar]
  45. Stoddart, C. A., Geleziunas, R., Ferrell, S., Linquist-Stepps, V., Moreno, M. E., Bare, C., Xu, W., Yonemoto, W., Bresnahan, P. A. & other authors ( 2003; ). Human immunodeficiency virus type 1 nef-mediated downregulation of CD4 correlates with nef enhancement of viral pathogenesis. J Virol 77, 2124–2133.[CrossRef]
    [Google Scholar]
  46. Tanaka, M., Ueno, T., Nakahara, T., Sasaki, K., Ishimoto, A. & Sakai, H. ( 2003; ). Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1. Virology 311, 316–325.[CrossRef]
    [Google Scholar]
  47. Tobiume, M., Takahoko, M., Yamada, T., Tatsumi, M., Iwamoto, A. & Matsuda, M. ( 2002; ). Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 nef from japanese long-term nonprogressors. J Virol 76, 5959–5965.[CrossRef]
    [Google Scholar]
  48. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B. & Guatelli, J. ( 2008; ). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral vpu protein. Cell Host Microbe 3, 245–252.[CrossRef]
    [Google Scholar]
  49. Wildum, S., Schindler, M., Munch, J. & Kirchhoff, F. ( 2006; ). Contribution of vpu, env, and nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 80, 8047–8059.[CrossRef]
    [Google Scholar]
  50. Willey, R. L., Maldarelli, F., Martin, M. A. & Strebel, K. ( 1992; ). Human immunodeficiency virus type 1 vpu protein induces rapid degradation of CD4. J Virol 66, 7193–7200.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.026005-0
Loading
/content/journal/jgv/10.1099/vir.0.026005-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error